from work, child care, and transportation could also improve access to clinical trials for lower-income patients.Future research should investigate how to overcome financial barriers to clinical trial participation.The identification of patient income level as an independent predictor of trial participation is important for multiple reasons.If income is associated with health status, then improving representativeness of lower-income patients in trials would improve the generalizability of study outcomes.Also, greater participation of lower-income patients would allow trials to be conducted more quickly, speeding the development of new treatments.Crucially, since clinical trial treatments represent the newest available treatments, access to this vital resource should be available to individuals of all income levels.
No takes yet. Share an insight, caveat, or question.
Abola et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: